Your session is about to expire
← Back to Search
Neuromodulation
Interstim Parameter Frequency 40 HZ for Sexual Dysfunction
Phase 4
Waitlist Available
Led By Kristene E Whitmore, MD
Research Sponsored by Pelvic and Sexual Health Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female with diagnosis of IC/PBS with implanted IPG Interstim.
Scores > 8 on the Interstitial Cystitis Symptom index questionnaire (ICSI) and > 8 on the Interstitial Cystitis Problem Index questionnaire (ICPI).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
Purpose: To demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard). The evaluate the efficacy of the two frequency settings on the other associated conditions that often coexist in patients with IC/PBS, such as female sexual dysfunction (FSD), bowel dysfunction, high tone pelvic floor dysfunction (HTPFD, painful spasm of the pelvic floor muscles), Vulvodynia (pain at the opening of the vagina).
Eligible Conditions
- Sexual Dysfunction
- Pelvic Floor Dysfunction
- Interstitial Cystitis
- Irritable Bowel Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement in Urinary symptoms and Bladder pain/discomfort
Secondary outcome measures
Improvement in Bowel symptoms and Sexual Function
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Interstim Parameter Frequency 40 HZExperimental Treatment1 Intervention
Subjects in this arm will receive 40 Hz as their frequency for the first three months. For the second 3 months, these patients will receive 14 Hz. Six months after the devise has been implanted, the patient has the option to choose which frequency they feel allows for better symptom control, and this is how the devise will be programmed.
Group II: Interstim Parameter Frequency 14 HZActive Control1 Intervention
Subjects in this arm will receive 14 Hx as their frequency for the first three months. For the second 3 months, these patients will receive 40 Hz. Six months after the devise has been implanted, the patient has the option to choose which frequency they feel allows for better symptom control, and this is how the devise will be programmed.
Find a Location
Who is running the clinical trial?
Pelvic and Sexual Health InstituteLead Sponsor
2 Previous Clinical Trials
68 Total Patients Enrolled
Kristene E Whitmore, MDPrincipal InvestigatorDrexel University College of Medicine
2 Previous Clinical Trials
37 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger